rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2001-5-31
|
pubmed:abstractText |
Transsphenoidal surgery is the preferred treatment modality for growth hormone (GH)-secreting pituitary adenomas. In many series, the reported postoperative remission is based mainly on achievement of GH levels less than 2 ng/ml. Strict criteria for insulin-like growth factor I normalization and even lower GH levels (<1 ng/ml) are now suggested to define cure of acromegaly, but the evidence does not yet support such low GH levels in epidemiological follow-up. We analyzed our postoperative results in a large cohort of patients with acromegaly.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0148-396X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1239-43; discussion 1244-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11383725-Acromegaly,
pubmed-meshheading:11383725-Adult,
pubmed-meshheading:11383725-Aged,
pubmed-meshheading:11383725-Cohort Studies,
pubmed-meshheading:11383725-Endocrine Glands,
pubmed-meshheading:11383725-Female,
pubmed-meshheading:11383725-Follow-Up Studies,
pubmed-meshheading:11383725-Human Growth Hormone,
pubmed-meshheading:11383725-Humans,
pubmed-meshheading:11383725-Male,
pubmed-meshheading:11383725-Middle Aged,
pubmed-meshheading:11383725-Neurosurgical Procedures,
pubmed-meshheading:11383725-Postoperative Complications,
pubmed-meshheading:11383725-Postoperative Period,
pubmed-meshheading:11383725-Remission Induction,
pubmed-meshheading:11383725-Sphenoid Bone
|
pubmed:year |
2001
|
pubmed:articleTitle |
Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients.
|
pubmed:affiliation |
Institute of Endocrinology, Chaim Sheba Medical Center, Tel-Hashomer, Israel. i_shimon@netvision.net.il
|
pubmed:publicationType |
Journal Article
|